Bridgeway Capital Management’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.2K Sell
35,000
-18,358
-34% -$37.8K ﹤0.01% 1183
2026
Q1
$72K Sell
53,358
-50,000
-48% -$100K ﹤0.01% 1164
2025
Q4
$269K Sell
103,358
-17,695
-15% -$48.4K 0.01% 959
2025
Q3
$363K Hold
121,053
– – 0.01% 873
2025
Q2
$487K Buy
121,053
+71,053
+142% +$262K 0.01% 782
2025
Q1
$166K Buy
+50,000
New +$238K ﹤0.01% 956

Other funds holding BTMD

Bridgeway Capital Management's BTMD Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Biote Corp (BTMD) stake by 34% in Q2 2026, selling an estimated $37.8K and leaving 35,000 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Bridgeway Capital Management first reported a position in BTMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $487K in Q2 2025. 71 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

  • Bridgeway Capital Management held 35,000 shares of Biote Corp worth $66.2K as of Q2 2026.
  • Bridgeway Capital Management sold 18,358 Biote Corp shares in Q2 2026, an estimated $37.8K.
  • Biote Corp made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1183 holding.
  • Bridgeway Capital Management first reported a position in Biote Corp in Q1 2025 and has held it in 6 quarters since.
  • Bridgeway Capital Management's Biote Corp position peaked at $487K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.